Authors: Dreger P; University Hospital Heidelberg, Department of Hematology & Oncology, Heidelberg, Germany. peter.dreger@med.uni-heidelberg.de., Holtick U; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Subklewe M; University Hospital Munich (LMU Munich), Department of Hematology & Oncology, Munich, Germany., von Tresckow B; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Ayuk F; University Hospital Hamburg, Department for Stem Cell Transplantation, Hamburg, Germany., Wagner E; University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany., Wulf G; University Medicine Goettingen, Clinic for Hematology & Medical Oncology, Göttingen, Germany., Marks R; University Hospital Freiburg, Department of Hematology & Oncology, Freiburg, Germany., Penack O; University Hospital Charite, Department of Hematology & Oncology, Berlin, Germany., Schnetzke U; University Hospital Jena, Department of Hematology & Oncology, Jena, Germany., Koenecke C; University Hospital Hannover, Department of Hematology & Oncology, Hannover, Germany., von Bonin M; University Hospital Dresden, Department of Hematology & Oncology, Dresden, Germany., Stelljes M; University Hospital Muenster, Department of Hematology & Oncology, Muenste, Germany., Glass B; Klinikum Berlin-Buch, Department of Hematology & Oncology, Berlin, Germany., Baldus CD; University Hospital Kiel, Department of Hematology & Oncology, Kiel, Germany., Vucinic V; University Hospital Leipzig, Leipzig, Germany., Mougiakakos D; University Hospital Erlangen, Department of Hematology & Oncology, Erlangen, currently University Hospital Magdeburg, Department of Hematology, Magdeburg, Germany., Topp M; University Hospital Würzburg, Department of Hematology & Oncology, Würzburg, Germany., Schroers R; University Hospital Bochum, Department of Hematology & Oncology, Bochum, Germany., Wolff D; University Hospital Regensburg, Department ofInternal Medicine III, Hematology and Oncology, Regensburg, Germany., Thomas S; University Hospital Regensburg, Department ofInternal Medicine III, Hematology and Oncology, Regensburg, Germany.; Leibniz Institute for Immunotherapy, Regensburg, Germany., Kröger N; University Hospital Hamburg, Department for Stem Cell Transplantation, Hamburg, Germany., Bethge WA; University Hospital Tuebingen, Department of Hematology & Oncology, Tuebingen, Germany.

Corporate Authors: German Lymphoma Alliance (GLA), German Stem Cell Transplantation Registry (DRST)

Source: Bone marrow transplantation [Bone Marrow Transplant] 2023 Feb; Vol. 58 (2), pp. 229-232. Date of Electronic Publication: 2022 Nov 22.

Publication Type: Letter; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Lymphoma, Large B-Cell, Diffuse*/therapy, Humans ; T-Lymphocytes ; Antigens, CD19

Authors: Bodmer W; Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford, UK. walter.bodmer@hertford.ox.ac.uk.

Source: British journal of cancer [Br J Cancer] 2023 Feb; Vol. 128 (3), pp. 419-420. Date of Electronic Publication: 2022 Dec 07.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neoplasms*/therapy, Humans ; Antibodies, Monoclonal/therapeutic use ; T-Lymphocytes

Authors: Zhou D; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Wang Y; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Cheng H; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Zhu L; Department of Pediatrics, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China., Chen W; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Li H; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Zhang X; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Xia J; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Qi Y; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Ma S; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Zhu F; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Yan Z; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Qi K; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Sang W; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Sun H; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Li D; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China., Cao J; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China. Electronic address: zimu05067@163.com., Li Z; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China. Electronic address: lizhenyumd@163.com., Xu K; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China. Electronic address: lihmd@163.com.

Source: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2023 Feb; Vol. 29 (2), pp. 179-185. Date of Electronic Publication: 2022 Nov 08.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

MeSH Terms: Multiple Myeloma*/complications , Multiple Myeloma*/therapy , Receptors, Chimeric Antigen*/therapeutic use , Immunotherapy, Adoptive* , Infections*, Humans ; Neoplasm Recurrence, Local ; Retrospective Studies

Authors: Kannan B; Centre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai 600077, TN, India., Jayaseelan VP; Centre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai 600077, TN, India., Arumugam P; Centre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai 600077, TN, India. Electronic address: paramasivama.sdc@saveetha.com.

Source: Journal of stomatology, oral and maxillofacial surgery [J Stomatol Oral Maxillofac Surg] 2023 Feb; Vol. 124 (1S), pp. 101375. Date of Electronic Publication: 2022 Dec 29.

Publication Type: Editorial

Journal Info: Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 101701089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-7855 (Electronic) Linking ISSN: 24687855 NLM ISO Abbreviation: J Stomatol Oral Maxillofac Surg Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Mouth Neoplasms*/therapy, Humans ; Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism

Authors: Xu H; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Lv Q; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Cao W; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Wang J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Meng F; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Li C; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Zheng M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Chen L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Mu K; Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Cheng J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Zhu L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Zhou J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Zhang Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Wang N; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China. Electronic address: wangna.2001@163.com., Cao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China. Electronic address: caoyangemma@163.com.

Source: Cytotherapy [Cytotherapy] 2023 Feb; Vol. 25 (2), pp. 185-191. Date of Electronic Publication: 2022 Oct 22.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

MeSH Terms: Antigens, CD19*/immunology , Immunotherapy, Adoptive*/adverse effects , Lymphoma, B-Cell*/therapy , Receptors, Chimeric Antigen*/genetics , Receptors, Chimeric Antigen*/therapeutic use , Sialic Acid Binding Ig-like Lectin 2*/immunology, Humans ; Cell- and Tissue-Based Therapy ; Receptors, Antigen, T-Cell/genetics

Authors: Palani HK; Department of Haematology, Christian Medical College, Vellore, India., Arunachalam AK; Department of Haematology, Christian Medical College, Vellore, India., Yasar M; Department of Haematology, Christian Medical College, Vellore, India., Venkatraman A; Department of Haematology, Christian Medical College, Vellore, India., Kulkarni U; Department of Haematology, Christian Medical College, Vellore, India., Lionel SA; Department of Haematology, Christian Medical College, Vellore, India., Selvarajan S; Department of Haematology, Christian Medical College, Vellore, India., Korula A; Department of Haematology, Christian Medical College, Vellore, India., Abraham A; Department of Haematology, Christian Medical College, Vellore, India., George B; Department of Haematology, Christian Medical College, Vellore, India., Adair JE; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Orentas R; Caring Cross, Gaithersburg, MD, USA., Dropulic B; Lentigen, Technology, Inc., a Miltenyi Biotec Company, Gaithersburg, MD, USA.; Caring Cross, Gaithersburg, MD, USA., Mathews V; Department of Haematology, Christian Medical College, Vellore, India. vikram@cmcvellore.ac.in.

Source: Bone marrow transplantation [Bone Marrow Transplant] 2023 Feb; Vol. 58 (2), pp. 160-167. Date of Electronic Publication: 2022 Nov 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Neoplasms*, Humans ; Reproducibility of Results ; T-Lymphocytes ; Costs and Cost Analysis ; Antigens, CD19

Authors: Kiefer T; Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany; Medical University Brandenburg 'Theodor Fontane', Germany. Electronic address: Thomas.Kiefer-Trendelenburg@klinikamsee.com., Lüders C; Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany., Völler H; Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany; Universität Potsdam, Professur für Rehabilitationswissenschaften, humanwissenschaftliche Fakultät, Germany., Daeschlein G; Clinic of Dermatology, Immunology and Allergology, Medical Center Dessau, Medical University Brandenburg 'Theodor Fontane' Medical Center Dessau, Germany.

Source: Transplant immunology [Transpl Immunol] 2023 Feb; Vol. 76, pp. 101770. Date of Electronic Publication: 2022 Dec 05.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9309923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5492 (Electronic) Linking ISSN: 09663274 NLM ISO Abbreviation: Transpl Immunol Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Receptors, Chimeric Antigen*, Humans ; Antigens, CD19 ; Treatment Outcome

Authors: Knight JM; Department of Psychiatry; Medical College of Wisconsin; Milwaukee, WI, USA; Departments of Medicine and Microbiology and Immunology; Medical College of Wisconsin; Milwaukee, WI. jmknight@mcw.edu., Hackett E; Medical College of Wisconsin; Milwaukee, WI., Szabo A; Division of Biostatistics; Medical College of Wisconsin; Milwaukee, WI., Wu R; Division of Biostatistics; Medical College of Wisconsin; Milwaukee, WI., Sauber G; Department of Pharmacology and Toxicology and Neuroscience Research Center; Medical College of Wisconsin; Milwaukee, WI., Johnson B; BMT and Cellular Therapy Program, Division of Hematology and Oncology; Medical College of Wisconsin; Milwaukee, WI., Cusatis RN; Department of Medicine, Division of Hematology and Oncology; Medical College of Wisconsin; Milwaukee, WI., Aughey E; Medical College of Wisconsin; Milwaukee, WI., Cole SW; Departments of Psychiatry and Biobehavioral Sciences and Medicine, Division of Hematology-Oncology; David Geffen School of Medicine at UCLA; Los Angeles, CA., Hillard CJ; Department of Pharmacology and Toxicology and Neuroscience Research Center; Medical College of Wisconsin; Milwaukee, WI., Shah NN; BMT and Cellular Therapy Program, Division of Hematology and Oncology; Medical College of Wisconsin; Milwaukee, WI.

Source: Haematologica [Haematologica] 2023 Feb 01; Vol. 108 (2), pp. 588-593. Date of Electronic Publication: 2023 Feb 01.

Publication Type: Letter

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Receptors, Chimeric Antigen*, Humans ; T-Lymphocytes ; Social Class

Authors: Chen G; Department of Medicine, Transplant and Cellular Therapy Program. George.chen@roswellpark.org., Herr M; Department of Medicine, Transplant and Cellular Therapy Program., Nowak J; Department of Pathology., Ho C; Department of Medicine, Transplant and Cellular Therapy Program., Almyroudis N; Department of Internal Medicine, Division of Infectious Diseases., Attwood K; Department of Biostatistics., Bonnewell J; Department of Internal Medicine, Division of Infectious Diseases., Walsh M; Department of Internal Medicine, Division of Infectious Diseases., Segal B; Department of Internal Medicine, Division of Infectious Diseases., Ross M; Department of Medicine, Transplant and Cellular Therapy Program., McCarthy P; Department of Medicine, Transplant and Cellular Therapy Program., Hahn T; Department of Cancer Prevention and Control.

Source: Haematologica [Haematologica] 2023 Feb 01; Vol. 108 (2), pp. 615-620. Date of Electronic Publication: 2023 Feb 01.

Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/adverse effects , Lymphoma, B-Cell*/therapy, Humans ; Cytomegalovirus ; T-Lymphocytes ; Antigens, CD19 ; Receptors, Antigen, T-Cell

Authors: Zhang DKY; John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; The Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA., Adu-Berchie K; John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; The Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA., Iyer S; John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; The Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA., Liu Y; John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; The Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA., Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Brockman JM; John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; The Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mooney DJ; John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA. mooneyd@seas.harvard.edu.; The Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA. mooneyd@seas.harvard.edu.

Source: Nature communications [Nat Commun] 2023 Jan 31; Vol. 14 (1), pp. 506. Date of Electronic Publication: 2023 Jan 31.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

MeSH Terms: T-Lymphocytes* , Immunotherapy, Adoptive*, Antigen-Presenting Cells ; Antigens, CD19 ; Humans ; Receptors, Chimeric Antigen

Authors: Yang J; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China., Zhou W; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China., Li D; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China., Niu T; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China. Electronic address: niuting@wchscu.cn., Wang W; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China. Electronic address: weiwang@scu.edu.cn.

Source: Cancer letters [Cancer Lett] 2023 Jan 28; Vol. 553, pp. 215949. Date of Electronic Publication: 2022 Oct 08.

Publication Type: Review; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Multiple Myeloma*/therapy , Receptors, Chimeric Antigen*/genetics, Humans ; B-Cell Maturation Antigen ; Cell- and Tissue-Based Therapy ; T-Lymphocytes ; United States

Authors: Ou W; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA., Stewart S; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA., White A; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA., Kwizera EA; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA., Xu J; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA., Fang Y; Department of Medical and Molecular Genetics and Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA., Shamul JG; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA., Xie C; Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Nurudeen S; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, 21201, USA., Tirada NP; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, 21201, USA., Lu X; Department of Medical and Molecular Genetics and Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA., Tkaczuk KHR; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, 21201, USA., He X; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA. shawnhe@umd.edu.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, 21201, USA. shawnhe@umd.edu.

Source: Nature communications [Nat Commun] 2023 Jan 24; Vol. 14 (1), pp. 392. Date of Electronic Publication: 2023 Jan 24.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

MeSH Terms: Antineoplastic Agents*/immunology , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Immunotherapy*/methods , Neoplasms*/immunology , Neoplasms*/pathology , Tumor Microenvironment*/drug effects , Tumor Microenvironment*/immunology , Cryotherapy*/methods, Animals ; Female ; Mice ; Cell Line, Tumor ; Nanotechnology/methods

Authors: Zhang B; Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Yuan Q; Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Zhang B; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, University Medical Center Halle, Halle, Germany., Li S; Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Wang Z; Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Liu H; Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Meng F; Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Chen X; Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Shang D; Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Jan 20; Vol. 13, pp. 1078424. Date of Electronic Publication: 2023 Jan 20 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/genetics, Humans ; Interleukin-18 ; Prognosis ; Reproducibility of Results ; Tumor Microenvironment

SCR Disease Name: Pancreatic Carcinoma

Authors: Seya T; Nebuta Research Institute for Life Sciences, Aomori University, Aomori 030-0943, Japan.; Department of Vaccine Immunology, Hokkaido University Graduate School of Medicine, and Hokkaido University International Institute for Zoonosis Control, Sapporo 060-8638, Japan.

Source: Cells [Cells] 2023 Jan 19; Vol. 12 (3). Date of Electronic Publication: 2023 Jan 19.

Publication Type: Editorial

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Immunity, Innate*, Humans

Authors: Gupta S; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Simic M; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Sagan SA; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Shepherd C; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Duecker J; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Sobel RA; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Dandekar R; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Wu GF; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Wu W; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Pak JE; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Hauser SL; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Lim W; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Wilson MR; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Zamvil SS; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA. zamvil@ucsf.neuroimmunol.org.

Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2023 Jan 19; Vol. 10 (2). Date of Electronic Publication: 2023 Jan 19 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE

MeSH Terms: Encephalomyelitis, Autoimmune, Experimental*/drug therapy , Immunotherapy, Adoptive*, Animals ; Humans ; Mice ; Antibodies, Monoclonal ; Antigens, CD19 ; Autoimmunity ; Central Nervous System ; Mice, Inbred C57BL ; Multiple Sclerosis/drug therapy ; Myelin-Oligodendrocyte Glycoprotein ; T-Lymphocytes ; B-Lymphocytes

Authors: Gong X; Department of Biomedical Engineering, Johns Hopkins University, 217A Hackerman Hall, 3400 N. Charles St., Baltimore, MD, 21218, USA.; Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD, 21218, USA., Karchin R; Department of Biomedical Engineering, Johns Hopkins University, 217A Hackerman Hall, 3400 N. Charles St., Baltimore, MD, 21218, USA. karchin@jhu.edu.; Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD, 21218, USA. karchin@jhu.edu.; Department of Oncology, Johns Hopkins Medicine, Baltimore, MD, 21287, USA. karchin@jhu.edu.

Source: Scientific reports [Sci Rep] 2023 Jan 18; Vol. 13 (1), pp. 950. Date of Electronic Publication: 2023 Jan 18.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Melanoma*/drug therapy , Melanoma*/genetics, Humans ; Immune Checkpoint Inhibitors

Authors: Forero-Forero JV; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Lengerke-Diaz PA; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Moreno-Cortes E; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Melody M; Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA., Rahman ZA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL, USA., Rosenthal AC; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL, USA., Castro JE; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA.

Source: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2023 Jan 17; Vol. 16 (2), pp. 133-143. Date of Electronic Publication: 2023 Jan 17.

Publication Type: Journal Article

Journal Info: Publisher: Scientific Publications Country of Publication: Saudi Arabia NLM ID: 101468532 Publication Model: Electronic Cited Medium: Internet ISSN: 2589-0646 (Electronic) Linking ISSN: 25890646 NLM ISO Abbreviation: Hematol Oncol Stem Cell Ther Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/adverse effects , Lymphoma, Large B-Cell, Diffuse*, Humans ; Retrospective Studies ; Neoplasm Recurrence, Local ; Chronic Disease

Authors: Wang L; Division of Genetics, Department of Pediatrics, Program in Immunology, Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA., Wu L; Division of Genetics, Department of Pediatrics, Program in Immunology, Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA., Zhu Z; Division of Genetics, Department of Pediatrics, Program in Immunology, Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA., Zhang Q; Division of Genetics, Department of Pediatrics, Program in Immunology, Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA., Li W; Division of Genetics, Department of Pediatrics, Program in Immunology, Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA., Gonzalez GM; Environmental Toxicology Graduate Program and Department of Chemistry, University of California, Riverside, CA, USA., Wang Y; Environmental Toxicology Graduate Program and Department of Chemistry, University of California, Riverside, CA, USA., Rana TM; Division of Genetics, Department of Pediatrics, Program in Immunology, Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA.; San Diego Center for Precision Immunotherapy, University of California San Diego, La Jolla, CA, USA.

Source: The EMBO journal [EMBO J] 2023 Jan 16; Vol. 42 (2), pp. e111673. Date of Electronic Publication: 2022 Dec 14.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Blackwell Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE

MeSH Terms: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Immunotherapy*, Animals ; Humans ; Mice ; Adaptor Proteins, Signal Transducing/metabolism ; Membrane Proteins/metabolism ; Methylation ; Nuclear Proteins/metabolism ; RNA, Messenger/genetics ; RNA-Binding Proteins/metabolism ; Transforming Growth Factor beta/metabolism

Authors: Rouhani SJ; University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA.; Department of Medicine, University of Chicago, Chicago, Illinois, USA., Bestvina CM; University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA.; Department of Medicine, University of Chicago, Chicago, Illinois, USA.

Source: Cancer [Cancer] 2023 Jan 15; Vol. 129 (2), pp. 181-183. Date of Electronic Publication: 2022 Nov 24.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy*, Humans

Authors: Tan L; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Xiaohalati X; Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Liu F; Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Liu J; Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Fu H; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Zhang Y; Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Gao J; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Tao K; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Wang G; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Wang L; Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Wang Z; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jan 12; Vol. 24 (2). Date of Electronic Publication: 2023 Jan 12.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Colorectal Neoplasms*/diagnosis , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/therapy, Humans ; Aging ; Algorithms ; Angiogenesis Inhibitors